SCGB3A1

Across TCGA pan-cancer cohorts, SCGB3A1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SCGB3A1 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SCGB3A1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SCGB3A1 expression acts as an unfavorable survival marker.

LUAD and LSCC are the cancer types where SCGB3A1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	III,IV	0.316	0.695	<.001	39	view →
LSCC	OS	Median	II,III,IV	0.887	1.000	.029	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SCGB3A1–LUAD (DFS)

Open the LUAD breakdown →